Biochemistry & Pharmacology: Open Access

Biochemistry & Pharmacology: Open Access
Open Access

ISSN: 2167-0501

Purushottamachar p. Puranik

Purushottamachar p. Puranik
Department of Pharmacology and Experimental Therapeutics
University of Maryland, USA

Biography

Dr. Purushottamachar Puranik received his PhD in Pharmaceutical Chemistry in 2003 from the UICT Mumbai, India. He worked as process chemist in industry (USV Ltd., India) from 2003 to 2004. He undergone postdoctoral training at University of Maryland, Baltimore (UMB) and Thomas Jeffreson University, Philadelphia (2005 - 2010). In 2011 he was promoted to Research instructor position and he subsequently (2012) returned to UMB/CBT as a research associate. Dr. Puranik′s research spans the disciplines of pharmaceutical and biomolecular chemistry. Areas of interest are computer aided drug design, organic synthesis, and biological evaluation. His research is focused on design, synthesis and evaluation of Androgen Receptor Down-regulating agents (ARDAs) and Retinoic acid Metabolism Blocking agents (RAMBAs) for Prostate and Breast cancer. Dr. Puranik has a track record of publications in peer-reviewed scientific journals and presenation at various conferences. He is an Editorial Board Member and reviwer of a number of international journals.

Research Interest

Dr. Purushottamachar Puranik received his PhD in Pharmaceutical Chemistry in 2003 from the UICT Mumbai, India. He worked as process chemist in industry (USV Ltd., India) from 2003 to 2004. He undergone postdoctoral training at University of Maryland, Baltimore (UMB) and Thomas Jeffreson University, Philadelphia (2005 - 2010). In 2011 he was promoted to Research instructor position and he subsequently (2012) returned to UMB/CBT as a research associate. Dr. Puranik′s research spans the disciplines of pharmaceutical and biomolecular chemistry. Areas of interest are computer aided drug design, organic synthesis, and biological evaluation. His research is focused on design, synthesis and evaluation of Androgen Receptor Down-regulating agents (ARDAs) and Retinoic acid Metabolism Blocking agents (RAMBAs) for Prostate and Breast cancer. Dr. Puranik has a track record of publications in peer-reviewed scientific journals and presenation at various conferences. He is an Editorial Board Member and reviwer of a number of international journals.

Top